亚马逊药房扩大零售业务，快捷药方恢复药物趋势报告-动脉网

Amazon Pharmacy Expands Retail Presence as Express Scripts Revives Drug Trend Report

GeneOnline 等信源发布 2025-06-06 19:11



可切换为仅中文







by Mark Chiang

马克·蒋

Share To

分享到

In April 2025, several notable developments emerged in the pharmaceutical and healthcare sectors, highlighting key trends and updates. Amazon Pharmacy continues to expand its presence in retail pharmacy, signaling ongoing competition with traditional players. Express Scripts has revived its long-dormant drug trend report, offering insights into spending patterns and prescription drug utilization.

2025年4月，制药和医疗保健领域出现了几项显著的发展，突显了关键趋势和更新。亚马逊药房继续扩大其在零售药房领域的影响力，表明与传统参与者的竞争仍在持续。快捷药方公司重新启动了其长期休眠的药物趋势报告，提供了有关支出模式和处方药使用的见解。

Additionally, discussions around “gold cards” for prior authorization have gained traction, raising questions about their potential benefits or risks. Meanwhile, debates surrounding CMS acronyms and their implications remain a topic of interest..

此外，关于事先授权的“金卡”的讨论得到了关注，引发了人们对其潜在好处或风险的质疑。同时，围绕CMS缩略词及其含义的争论仍然是一个备受关注的话题。

Amazon Pharmacy’s continued push into retail pharmacy underscores the company’s ambitions to reshape how consumers access medications. Express Scripts’ updated drug trend report provides data on prescription drug spending trends after years of inactivity in this area. The concept of “gold cards,” which aim to streamline prior authorization processes for certain providers based on their track record, has sparked debate over whether they represent progress or pose challenges for patient care.

亚马逊药房继续进军零售药房领域，凸显了该公司重塑消费者获取药物方式的雄心。快捷处方更新的药物趋势报告提供了多年未涉及的处方药支出趋势数据。“金卡”概念旨在根据某些供应商的历史记录简化事先授权流程，这一概念引发了关于其代表进步还是对患者护理构成挑战的争论。

Lastly, the complexity of CMS-related terminology remains a point of contention among industry professionals as they navigate regulatory frameworks..

最后，CMS相关术语的复杂性仍然是行业专业人士在应对监管框架时争论的焦点。

These developments reflect ongoing shifts within the pharmaceutical landscape as companies adapt to evolving consumer needs and regulatory environments.

这些发展反映了制药行业内部的持续变化，因为企业正在适应不断变化的消费者需求和监管环境。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: April 28, 2025

日期：2025年4月28日

Biosimilars Reshape Europe’s Generic Drug Market, Offering Up to 30% Cost Savings for Patients

生物仿制药重塑欧洲仿制药市场，为患者提供高达30%的成本节约

DrugPatentWatch.com Article Highlights Focus on R&D, Continuous Improvement, and Quality Control for High-Quality Generic Drugs

DrugPatentWatch.com 文章重点：专注于研发、持续改进和质量控制以生产高质量仿制药

AACR Meeting Spotlights New Cancer Drug, Early Detection Tool, Canine Scent Research, and Vaccine Data